Spok Holdings Inc is a provider of healthcare communications... Show more
Spok Holdings is a niche leader in clinical communications and collaboration for healthcare. Its Spok Care Connect platform integrates with hospital contact centers, electronic health records, and other core IT systems, while its wireless segment operates the largest paging network in the United States. With more than 2,200 hospital customers and an average relationship tenure of roughly 26 years, Spok enjoys deep, entrenched ties to many top-ranked U.S. hospitals.
The company's structural strength lies in its recurring-revenue model — more than 80% of revenue comes from recurring software maintenance, managed services, and wireless fees — supported by a debt-free balance sheet and healthy gross margins near 80%. This cash-generative profile underpins a shareholder-return strategy that has returned substantial capital since 2004.
The medium-term challenge is the transition underway between two businesses moving in opposite directions. Software revenue is growing, driven by double-digit expansion in managed services, while wireless (paging) revenue continues a gradual, managed decline as units in service shrink. Spok's strategic positioning depends on converting its installed base and hospital relationships into faster software adoption while preserving wireless cash flow for as long as possible.
Several developments could shape investor sentiment over the coming quarters. First, software bookings momentum is a direct growth catalyst. Management reported a 92% sequential jump in software operations bookings in the second quarter of 2026, including one of the largest contracts in company history, though executives cautioned that such "whale" deals are inherently lumpy.
Second, AI adoption represents an emerging operational lever. Spok is applying artificial intelligence to shorten product development timelines and reduce time-to-market for new Care Connect capabilities, which could support margin durability even as revenue growth remains modest.
Third, spectrum asset monetization — the completed $8 million sale of certain narrowband licenses — illustrates how the company can unlock value from underutilized assets to fund both product investment and its dividend.
Fourth, capital allocation decisions, particularly the sustainability of the dividend, will be closely watched. With a payout ratio that has periodically exceeded earnings, the dividend's durability depends on maintained adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization), which management guided to a $30 million midpoint for 2026.
Finally, analyst ratings and price targets have turned more cautious. Coverage remains very thin — typically one to two firms — and while B. Riley Securities reiterated a Buy with a $21 target in late 2025, more recent published targets have settled near $14–$15, reflecting tempered top-line expectations and execution risk from wireless decline and cancellable backlog.
Spok operates at the intersection of healthcare IT spending and hospital economics. Hospitals face persistent fiscal pressure from reimbursement uncertainty and labor costs, which is driving demand for efficient, HIPAA (Health Insurance Portability and Accountability Act) compliant communications solutions — but also lengthening deal cycles and pushing customers toward shorter-term, lower-commitment agreements.
Interest-rate dynamics matter less to Spok than to leveraged peers, given its debt-free balance sheet, but they do influence the relative appeal of its high dividend yield. In a lower-rate environment, a double-digit yield can attract income-focused investors; conversely, sustained higher rates can raise the opportunity cost of holding a low-growth equity.
On the competitive front, the broader shift toward integrated healthcare platforms and AI-enabled clinical communication creates both opportunity and threat. Spok's strong satisfaction rankings in secure messaging and critical alert management are an advantage, but displacement risk remains if large hospital systems consolidate onto broader vendor suites. Regulatory and cybersecurity requirements also work in Spok's favor, as hospitals seek compliant, purpose-built communication tools.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool designed to help traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the coming week or month. By analyzing developing patterns, the engine aims to highlight possible breakouts or reversals and offers searchable prediction categories, historical context, and alert-oriented functionality across a wide range of tradable instruments. For investors evaluating SPOK alongside broader market signals, tools like the Trend Prediction Engine can provide an additional, data-driven perspective on short-term directional tendencies. Explore the Trend Prediction Engine to see how its AI-driven signals may complement your own research.
For 2026, Spok's guidance points to roughly flat total revenue at the midpoint of $136 million, with software revenue in the $65.5–$69.5 million range and adjusted EBITDA near $30 million. The company is effectively managing a transition: software and managed services are becoming the growth engine, while wireless decline is expected to persist.
Several long-term themes will define the trajectory beyond 2026. Market expansion hinges on converting its entrenched hospital base into deeper software adoption and, over time, winning new customers — a historically slow area, as the majority of new bookings still come from existing accounts. Margin sustainability will depend on disciplined cost control, the success of AI-driven efficiencies, and the mix shift toward higher-value managed services.
Technology transitions toward cloud-based and AI-enhanced clinical communication present both an opportunity to modernize the Care Connect platform and a threat from larger, better-capitalized competitors. Capital allocation priorities will remain a defining feature: Spok has signaled its intent to balance product investment with substantial shareholder returns, a strategy that is only viable if free cash flow holds up as wireless declines.
Consensus expectations reflect a measured view — stable-to-modest growth with disciplined execution — rather than aggressive expansion. How effectively Spok accelerates software bookings, monetizes remaining assets, and sustains its dividend will likely determine whether current analyst price targets are revised upward or remain constrained.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BESO | 32.84 | 1.10 | +3.48% |
| GSR Crypto Core3 ETF (BESO) | |||
| IDV | 43.54 | 1.25 | +2.96% |
| iShares International Select Dividend ETF (IDV) | |||
| TMFS | 35.34 | 0.86 | +2.49% |
| Motley Fool Small-Cap Growth ETF (TMFS) | |||
| NPFE | 28.97 | 0.59 | +2.08% |
| NPF Core Equity ETF (NPFE) | |||
| WEEK | 99.99 | -0.03 | -0.03% |
| Roundhill Weekly T-Bill ETF | |||
A.I.dvisor indicates that over the last year, SPOK has been loosely correlated with EVTC. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SPOK jumps, then EVTC could also see price increases.
| Ticker / NAME | Correlation To SPOK | 1D Price Change % | ||
|---|---|---|---|---|
| SPOK | 100% | +0.58% | ||
| EVTC - SPOK | 41% Loosely correlated | +11.10% | ||
| DOX - SPOK | 37% Loosely correlated | -30.07% | ||
| QLYS - SPOK | 36% Loosely correlated | +0.15% | ||
| EEFT - SPOK | 36% Loosely correlated | +6.66% | ||
| OSPN - SPOK | 34% Loosely correlated | -3.23% | ||
More | ||||
| Ticker / NAME | Correlation To SPOK | 1D Price Change % |
|---|---|---|
| SPOK | 100% | +0.58% |
| Services to the Health Industry industry (42 stocks) | 11% Poorly correlated | -3.64% |
| Health Services industry (239 stocks) | 4% Poorly correlated | -4.59% |
a holding company, which through its subsidiary provides wireless messaging, mobile voice and data and unified communications solutions
Industry ServicestotheHealthIndustry
SPOK's Aroon Indicator triggered a bullish signal on October 20, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 227 similar instances where the Aroon Indicator showed a similar pattern. In 170 of the 227 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 75%.
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on SPOK as a result. In 68 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for SPOK just turned positive on October 29, 2026. Looking at past instances where SPOK's MACD turned positive, the stock continued to rise in 35 of 47 cases over the following month. The odds of a continued upward trend are 74%.
SPOK moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for SPOK crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 59%.
Following a +2.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where SPOK advanced for three days, in 184 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPOK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
SPOK broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.805) is normal, around the industry mean (4.886). P/E Ratio (20.810) is within average values for comparable stocks, (13.782). Projected Growth (PEG Ratio) (0.360) is also within normal values, averaging (2.133). SPOK's Dividend Yield (0.104) is considerably higher than the industry average of (0.011). P/S Ratio (1.671) is also within normal values, averaging (6.065).
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. SPOK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 48 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 76 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.